Obsidian Therapeutics (OBX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $12.20, -0.16% vs the prior close of $12.22.
- Volume 240.30K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OBX ends flat (-0.2%) to $12.20. Closed at $12.20, -0.16% vs the prior close of $12.22. Day range $12.06–$12.67, opened at $12.31.
OBX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — OBX ends flat (-0.2%) to $12.20
- Closed at $12.20, -0.16% vs the prior close of $12.22. Day range $12.06–$12.67, opened at $12.31.
- Volume was 240.30K shares, 0.6x its 50-day average of 421.62K — lighter than usual.
- Price is -30.7% vs its 50-day average ($17.60).
- 52-week range $11.79–$49.97; today's close sits at 1% of that range, 75.6% below the 52-week high.
Oct 14, 2026 — OBX rises 1.9% to $12.22
- Closed at $12.22, +1.92% vs the prior close of $11.99. Day range $11.79–$12.67, opened at $12.00.
- Volume was 298.30K shares, 0.7x its 50-day average of 415.93K.
- Price is -31.8% vs its 50-day average ($17.93).
- 52-week range $11.79–$49.97; today's close sits at 1% of that range, 75.5% below the 52-week high.
Oct 13, 2026 — OBX slides 6.3% to $11.99, a 1-month low
- Closed at $11.99, -6.25% vs the prior close of $12.79. Day range $11.86–$13.18, opened at $12.96.
- Volume was 377.30K shares, 0.9x its 50-day average of 408.43K.
- Price is -34.7% vs its 50-day average ($18.36).
- 52-week range $11.86–$49.97; today's close sits at 0% of that range, 76.0% below the 52-week high.
Oct 12, 2026 — OBX dips 1.6% to $12.79
- Closed at $12.79, -1.62% vs the prior close of $13.00. Day range $12.61–$13.21, opened at $13.13.
- Volume was 420.00K shares, 1.0x its 50-day average of 400.03K.
- Price is -30.9% vs its 50-day average ($18.50).
- 52-week range $12.07–$49.97; today's close sits at 2% of that range, 74.4% below the 52-week high.
Oct 9, 2026 — OBX jumps 6.2% to $13.00
- Closed at $13.00, +6.21% vs the prior close of $12.24. Day range $12.25–$13.95, opened at $12.25.
- Volume was 532.20K shares, 1.4x its 50-day average of 389.38K.
- Price is -29.9% vs its 50-day average ($18.56).
- 52-week range $12.07–$49.97; today's close sits at 2% of that range, 74.0% below the 52-week high.
Oct 8, 2026 — OBX slides 7.3% to $12.24, a 1-month low, 3 down days in a row
- Closed at $12.24, -7.27% vs the prior close of $13.20. Day range $12.07–$13.39, opened at $13.14.
- Volume was 517.10K shares, 1.4x its 50-day average of 379.05K.
- Price is -34.2% vs its 50-day average ($18.61).
- 52-week range $12.07–$49.97; today's close sits at 0% of that range, 75.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — OBX ends flat (-0.2%) to $13.20
- Closed at $13.20, -0.15% vs the prior close of $13.22. Day range $12.80–$13.88, opened at $13.02.
- Volume was 359.00K shares, 1.0x its 50-day average of 371.87K.
- Price is -29.3% vs its 50-day average ($18.68).
- 52-week range $12.16–$49.97; today's close sits at 3% of that range, 73.6% below the 52-week high.
Oct 6, 2026 — OBX slides 4.5% to $13.22
- Closed at $13.22, -4.48% vs the prior close of $13.84. Day range $13.00–$14.42, opened at $13.84.
- Volume was 288.80K shares, 0.8x its 50-day average of 366.09K.
- Price is -29.4% vs its 50-day average ($18.72).
- 52-week range $12.16–$49.97; today's close sits at 3% of that range, 73.5% below the 52-week high.
Oct 5, 2026 — OBX rises 1.8% to $13.84
- Closed at $13.84, +1.84% vs the prior close of $13.59. Day range $13.09–$14.26, opened at $13.45.
- Volume was 199.20K shares, 0.5x its 50-day average of 369.50K — lighter than usual.
- Price is -26.4% vs its 50-day average ($18.81).
- 52-week range $12.16–$49.97; today's close sits at 4% of that range, 72.3% below the 52-week high.
Oct 2, 2026 — OBX rises 2.0% to $13.59
- Closed at $13.59, +2.03% vs the prior close of $13.32. Day range $13.07–$13.90, opened at $13.07.
- Volume was 229.00K shares, 0.6x its 50-day average of 372.43K.
- 52-week range $12.16–$49.97; today's close sits at 4% of that range, 72.8% below the 52-week high.
OBX latest news & SEC filings
Every SEC filing by or about OBX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 28, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $0
Aug 11, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade OBX
- Last results release: Aug 3, 2026 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 4.30% (largest 12.1%). That is a volatile stock.
- Liquidity: about 654.93K shares (≈$7.99M) trade per day on average.
- 52-week position: $12.20 vs a range of $11.79–$49.97 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 8-K Aug 3, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
OBX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 12.31 | 12.67 | 12.06 | 12.20 | 240.30K |
| Oct 14, 2026 | 12.00 | 12.67 | 11.79 | 12.22 | 298.30K |
| Oct 13, 2026 | 12.96 | 13.18 | 11.86 | 11.99 | 377.30K |
| Oct 12, 2026 | 13.13 | 13.21 | 12.61 | 12.79 | 420.00K |
| Oct 9, 2026 | 12.25 | 13.95 | 12.25 | 13.00 | 532.20K |
| Oct 8, 2026 | 13.14 | 13.39 | 12.07 | 12.24 | 517.10K |
| Oct 7, 2026 | 13.02 | 13.88 | 12.80 | 13.20 | 359.00K |
| Oct 6, 2026 | 13.84 | 14.42 | 13.00 | 13.22 | 288.80K |
| Oct 5, 2026 | 13.45 | 14.26 | 13.09 | 13.84 | 199.20K |
| Oct 2, 2026 | 13.07 | 13.90 | 13.07 | 13.59 | 229.00K |
| Oct 1, 2026 | 13.86 | 14.68 | 13.16 | 13.32 | 299.80K |
| Sep 30, 2026 | 14.58 | 14.70 | 13.11 | 13.73 | 351.60K |
| Sep 29, 2026 | 13.28 | 15.38 | 12.80 | 14.58 | 378.60K |
| Sep 28, 2026 | 12.91 | 13.73 | 12.33 | 13.37 | 913.00K |
| Sep 25, 2026 | 13.54 | 13.70 | 12.16 | 12.86 | 454.50K |
| Sep 24, 2026 | 15.27 | 15.66 | 13.20 | 13.41 | 426.60K |
| Sep 23, 2026 | 17.10 | 17.10 | 15.25 | 15.26 | 582.60K |
| Sep 22, 2026 | 17.44 | 17.97 | 16.71 | 17.00 | 1.15M |
| Sep 21, 2026 | 18.08 | 18.21 | 17.14 | 17.33 | 1.10M |
| Sep 18, 2026 | 17.61 | 18.16 | 17.36 | 17.75 | 3.97M |
About Obsidian Therapeutics
Obsidian Therapeutics (OBX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBRIDGE, MA. Fiscal year ends December 31. SEC CIK 2130606.
OBX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter Barrett | Director | Aug 5, 2026 |
| Maria Fardis | Director | Aug 5, 2026 |
| Heidi Hagen | Director | Aug 5, 2026 |
| Madan Jagasia | Chief Executive Officer | Aug 5, 2026 |
| Matthew Norkunas | Director | Aug 5, 2026 |
| Robert W. Ross | Director | Aug 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Julie B Feder | Chief Financial Officer | Aug 3, 2026 |
| Parameswaran Hari | Chief Medical Officer | Aug 3, 2026 |
| Madan Jagasia | Chief Executive Officer | Aug 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
OBX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $0, total liabilities $—, cash $— (as of Jun 30, 2026).
OBX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $18.99 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on OBX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.